Cybrexa Unveils Promising Preclinical Data on Tumor-Selective PDCs at ESMO 2025
Cybrexa Therapeutics presented preclinical data at the ESMO Targeted Anticancer Therapies Congress 2025, showcasing their alphalex™ peptide-drug conjugates (PDCs)....
Reunion Neuroscience Raises Post Pardum Depression at MMH Forum
Reunion Neuroscience is participating in the 2025 Maternal Mental Health (MMH) FORUM to discuss RE104, its lead product candidate...
2025 SCOPE Summit: Transforming Clinical Trials with Pragmatic Trial Approaches
The 2025 SCOPE Summit brought together industry leaders to explore integrating real-world data into clinical trials, focusing on pragmatic...
New Obesity Treatment Mechanisms: Dr. Bolz on Aphaia Pharma’s Innovative Approach
In this discussion with Steffen-Sebastian Bolz, MD, PhD, we explore Aphaia’s groundbreaking work in obesity treatment. With his dual...
Revolutionizing NSCLC Treatment: Insights from ImmunityBio’s CMO
In this discussion with Bobby Reddy, Chief Medical Officer of ImmunityBio, we delve into the innovative immunotherapy strategies targeting...
Pelareorep: A Game-Changer in Oncolytic Virus Therapy
In this conversation, we engage with Dr. Thomas Heineman, Chief Medical Officer of Oncolytics Biotech, to explore the innovative...
Transforming Clinical Trials: Medable’s Approach to Diversity and Inclusion
In this interview, we explore clinical trial technology’s impact on diversity and inclusion. Ali Holland from Medable shares insights...
Onward Medical Advances Parkinson’s Pipeline with DoD, MJFF Support
ONWARD Medical received two grants to support early clinical feasibility studies of its ONWARD ARC-IM System for Parkinson’s disease....
Adverum Launches Phase 3 Study of Ixo-Vec for Wet AMD
Adverum Biotechnologies has launched the ARTEMIS Phase 3 study, a pivotal trial evaluating the efficacy and safety of a...
Pliant Therapeutics Announces Update on Phase 2b/3 Idiopathic Pulmonary Fibrosis Trial
Pliant Therapeutics halted its Phase 2b BEACON-IPF trial of bexotegrast for idiopathic pulmonary fibrosis (IPF) due to an imbalance...